Drug intelligence / Profile preview

gardenia latifolia extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Gardenia latifolia extract is a botanical preparation derived from the leaves, bark, or fruit of the Gardenia latifolia plant (family Rubiaceae), commonly known as Indian boxwood or Ceylon boxwood. Traditionally used in South Asian medicine for ailments such as snake bites, skin diseases, stomach pain, dental caries, and fevers in livestock[2][3], this plant has been studied for its diverse pharmacological properties. Phytochemical analyses reveal that extracts (especially methanol and hydroalcoholic) are rich in bioactive compounds including flavonoids, phenols, saponins, terpenoids, tannins and alkaloids[2][5][6]. The major chemical constituents identified include pyrrolizine derivatives and other secondary metabolites[5]. Mechanistically: - The ethanol and hydroalcoholic extracts have demonstrated analgesic (pain-relieving), antipyretic (fever-reducing), anti-inflammatory effects comparable to standard drugs like paracetamol[1][3]. - They exhibit significant antioxidant activity via free radical scavenging assays[1][3][5]. - Antidiabetic activity is evidenced by α-amylase enzyme inhibition in vitro and improved glucose tolerance/insulin sensitivity in animal models of type 2 diabetes mellitus; efficacy was similar to metformin at higher doses[1][4]. - Antimicrobial effects against various pathogens have also been reported for different solvent fractions of the extract[1][2]. The mechanism of action appears to involve inhibition of prostaglandin synthesis (for analgesic/antipyretic effect)[1], reduction of oxidative stress through antioxidant pathways[3], modulation of carbohydrate metabolism enzymes such as α-amylase (antidiabetic effect)[1], enhancement of insulin sensitivity/glucose uptake pathways [4], membrane stabilization [1] and direct antimicrobial actions.

Other names
Gardenia latifolia Ait. extractIndian boxwood extractCeylon boxwood extractG. latifolia extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)AMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on gardenia latifolia extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gardenia latifolia extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call